Stone lab research was highlighted in Endocrine News. “We found that the proband carried mutations in the FGF21 receptor complex and performed tissue culture-based studies to demonstrate that these were functional/pathogenic mutations,” Stephen Stone, MD tells Endocrine News. “This study demonstrates the first ever link between FGF21 and severe insulin resistance.”